Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

KeyGene bolsters patents and licensing program

KeyGene has further strengthened its Next Generation Sequencing (NGS) patent estate by recent grants of patents in the United States, China, Hong Kong and India. Furthermore, KeyGene announces expansion of its out-licensing program. The company aims to enable service providers, research- and diagnostic product manufacturers as well as academic organizations globally to use and offer its patented technologies. Recently issued patents protecting methods for NGS-based variant detection include US 9,702,004, US 9,777,324, and US 9,745,627, ZL201410177894.1 (China and Hong-Kong) and 289590 and 287606 (India).

To serve its customers in crop improvement KeyGene has developed a number of highly sensitive and cost-effective NGS-based workflows. These methods enable discovery and detection of genetic variation, either naturally occurring or introduced via random mutagenesis. Methods included are Sequence-Based Genotyping, KeyPoint mutation screening and KeyGene SNPSelect. Beyond application in crops, these molecular indexing, barcoded amplicon and (exome) capturing approaches are powerful in today’s life sciences research and diagnostics. Application areas encompass farm animal breeding and human hereditary and somatic mutation detection including liquid biopsies.

KeyGene offers its patented NGS applications to customers and licensees and concluded more than twenty license agreements. To continue providing broad access to these powerful methods, KeyGene is committed to license interested parties in all fields of life sciences.

Arjen van Tunen, CEO of KeyGene, states: “NGS methods have revolutionized the way genetic analysis and molecular diagnostics are conducted today. They provide unparalleled sensitivity, speed and accuracy. Conventional detection platforms have been replaced by direct read-out of genetic variants at the sequence level, even when extremely rare. The revolutionary impact of NGS on research and diagnostics has now become truly visible and provides new opportunities for crop variety development to produce more food and feed and in the medical field to diagnose, prevent and cure diseases. We are committed to advance crop improvement using NGS and are also keen to see these methods being adopted in other fields of use.”

For more information:
KeyGene Netherlands
Agro Business Park 90
6708 PW Wageningen
The Netherlands

P.O. Box 216
6700 AE Wageningen
The Netherlands
T +31 (0)317 466 866
F +31 (0)317 424 939

Publication date: 1/12/2018



Other news in this sector:

4/20/2018 "Modern biology will maximize potential of vertical controlled-environment agriculture"
4/18/2018 Syngenta strengthens vegetable seed business in sweet corn
4/17/2018 "It's harder for varieties from overseas to enter Australian market"
4/17/2018 Presenting fruit quality of the past in modern varieties
4/17/2018 Spain: Sakata inaugurates new research centre in Almeria
4/17/2018 Plants are better in dealing with too much light than previously thought
4/17/2018 New tomato variety resistant to many insects
4/17/2018 US (IN): Career takes root in starting new plants
4/13/2018 France: New varieties shown at Indoor Lettuce Discovery Day
4/11/2018 Hazera launches new breeding & trial station in Turkey
4/6/2018 UF/IFAS expert urges scientists to breed for flavor
4/4/2018 US: Vegetable breeder launches two new celery lines
4/4/2018 Chinese breeder introduces colourful cherry tomatoes
3/30/2018 New breeding technologies successful to grow salt resistant crops
3/30/2018 Secretary Perdue issues USDA statement on plant breeding innovation
3/30/2018 US (CA): Seed Library of Los Angeles builds food security awareness
3/29/2018 US: Regulatory barriers to developing innovative agricultural biotechnology
3/28/2018 Vietnam: the rise of hydroponic lettuce
3/26/2018 KeyGene fortifies NGS patent licencing program
3/26/2018 Spain: New facilities for research on strawberries and raspberries